Guinea pig serum is the universal complement source for hemolytic assays — used in CH50 standardisation, complement fixation serology, and vaccine immunogenicity studies. The reason is simple: guinea pig complement has the highest activity per mL of any common laboratory animal and cross-reacts efficiently with sensitised sheep red blood cells. This guide covers selection, handling, and the most common mistakes.
Buy animal sera from EU stock
Request a quote – EU stock, batch documentation, lot reservation up to 36 months.
- Guinea Pig Serum – complement source
- Newborn Calf Serum (NCS) – US origin
- Newborn Calf Serum (NCS) – Australian origin
- Calf Serum (CS) – US origin
- Calf Serum (CS) – Australian origin
- Horse Serum – EU origin
- Donor Horse Serum (DHS)
- Normal Goat Serum (NGS)
- Normal Donkey Serum
- Normal Rabbit Serum (NRS)
- Normal Mouse Serum
- Rat Serum
- All animal sera – 16 species
Why guinea pig complement — not human, rabbit, or mouse?
| Species | Complement activity | Cross-reactivity with sRBC | Use in hemolytic assays |
|---|---|---|---|
| Guinea pig | ✅ Highest — 200–400 CH50/mL | ✅ Excellent | ✅ Standard reference |
| Human | Moderate — variable lot-to-lot | Good | For human complement-specific studies only |
| Rabbit | Moderate | Good | Occasionally — not standard |
| Mouse | Low — C5-deficient strains common | Poor | ⚠️ Not suitable for classical pathway CH50 |
| Rat | Low-moderate | Variable | Rarely used |
Guinea pig complement activates the classical complement pathway efficiently with sensitised sheep red blood cells (sRBCs coated with rabbit anti-sRBC IgM haemolysin) — the Mayer’s hemolytic system that has been the standard since the 1960s. Mouse complement is unsuitable for classical CH50 because many inbred mouse strains carry a C5 deficiency that eliminates lytic activity.
CH50 assay — what it measures and how
The 50% hemolytic complement (CH50) unit is defined as the amount of complement required to lyse 50% of a standardised suspension of sensitised sheep red blood cells under defined conditions. It measures total functional complement activity through the complete classical pathway (C1q through C9 — membrane attack complex).
Standard CH50 protocol overview:
- Prepare sensitised sRBCs: wash sRBCs to 5 × 10⁸ cells/mL in GVB buffer (gelatin-veronal-buffered saline, pH 7.4, Ca²⁺ and Mg²⁺), sensitise with rabbit anti-sRBC haemolysin at optimal haemolysin concentration (titrate fresh for each sRBC batch)
- Prepare complement dilutions: serial dilutions of guinea pig complement in ice-cold GVB buffer — typically 1:100 to 1:400 for standard guinea pig complement at 200+ CH50/mL
- Incubate: 30 min at 37°C — complement reacts with sensitised sRBCs, lysis begins
- Stop reaction: add ice-cold saline, centrifuge to pellet unlysed cells
- Measure: absorbance of supernatant at 541 nm (haemoglobin release) — 100% lysis control (distilled water) and 0% lysis control (no complement) for normalisation
- Calculate CH50: plot % lysis vs complement volume, interpolate 50% lysis point, calculate CH50/mL from the dilution factor
Critical handling requirements
- Storage: −80°C — not −20°C. Activity declines measurably at −20°C within weeks
- Never refreeze: single-use aliquots only. Freeze-thaw destroys complement activity. Pre-aliquot before freezing
- Thaw on ice: transfer from −80°C to ice-water bath — never warm to room temperature
- Use within 2–4 hours of thawing: activity declines rapidly on ice; use the same day
- Titrate fresh: always determine CH50 activity in your buffer and with your sRBC batch on the day of the assay — do not rely solely on the supplier’s CH50 value, which was measured under standard conditions that may differ from yours
Quality specifications to require
| Parameter | Requirement | Why |
|---|---|---|
| CH50 activity | ≥200 CH50/mL in GVB buffer | Sufficient activity for most hemolytic assay dilution series |
| Haemolysis | <5 mg/dL haemoglobin | Haemolytic complement gives false elevated background at 541 nm |
| Sterility | Sterile-filtered — sterility tested | Microbial contamination activates complement non-specifically |
| Endotoxin | <5 EU/mL | LPS activates alternative complement pathway — elevated background |
| Aliquot size | Single-use aliquots ≤1 mL | Prevents freeze-thaw cycling — critical for activity maintenance |
| Certificate of Analysis | CH50 activity, haemolysis, sterility, endotoxin | Required for GLP/GMP assay qualification |
Complement fixation tests — a different application
Complement fixation (CF) tests use guinea pig complement as a reagent to detect antigen-antibody complexes — historically the reference method for many viral and bacterial serologies (herpes, influenza, syphilis). In CF, complement is “fixed” (consumed) by antigen-antibody complexes; remaining free complement is then detected by adding sensitised sRBCs. No lysis = positive result (complement fixed). Full lysis = negative result (complement not fixed). CF tests require precisely titrated complement — typically at 2–5 CH50 units per well.
Guinea Pig Complement — High Activity, Single-Use Aliquots
SeamlessBio supplies guinea pig complement at ≥200 CH50/mL, pre-aliquoted for single use, with full CoA. EU stock, fast delivery.
